These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32549098)

  • 1. Predictive Value of Neutrophil-Lymphocyte Ratio for Long-Term Cardiovascular Event Following Coronary Artery Bypass Grafting.
    Gurbuz O; Kumtepe G; Ozkan H; Karal IH; Velioglu Y; Ercan A; Yüksel A; Ener S
    Braz J Cardiovasc Surg; 2020 Jun; 35(3):274-284. PubMed ID: 32549098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
    Xu N; Tang XF; Yao Y; Zhao X; Chen J; Gao Z; Yang Y; Gao RL; Xu B; Yuan JQ
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):551-557. PubMed ID: 29330938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive value of neutrophil to lymphocyte ratio on long-term outcomes of acute myocardial infarction patients with multivessel disease].
    Xu N; Tang XF; Xu JJ; Yao Y; Song Y; Liu R; Jiang L; Jiang P; Wang HH; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):42-48. PubMed ID: 30669809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery.
    Larmann J; Handke J; Scholz AS; Dehne S; Arens C; Gillmann HJ; Uhle F; Motsch J; Weigand MA; Janssen H
    BMC Cardiovasc Disord; 2020 May; 20(1):230. PubMed ID: 32423376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell distribution width predicts long term cardiovascular event after on-pump beating coronary artery bypass grafting.
    Gurbuz O; Kumtepe G; Ozkan H; Karal IH; Ercan A; Ener S
    J Cardiothorac Surg; 2016 Apr; 11():48. PubMed ID: 27059704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SYNTAX score is correlated with long-term outcomes of coronary artery bypass grafting for complex coronary artery lesions.
    Cho Y; Shimura S; Aki A; Furuya H; Okada K; Ueda T
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):125-32. PubMed ID: 26984964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
    Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy.
    Azab B; Shariff MA; Bachir R; Nabagiez JP; McGinn JT
    J Cardiothorac Surg; 2013 Sep; 8():193. PubMed ID: 24070055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pan-immune- inflammation value and in major cardiovascular and cerebrovascular events in stable coronary artery disease patients undergoing on-pump coronary artery bypass graft surgery.
    Dolapoglu A; Avci E
    J Cardiothorac Surg; 2024 Apr; 19(1):241. PubMed ID: 38632613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [No significant association between obesity and long-term outcome of coronary artery bypass grafting].
    Thorkelsdottir T; Johannesdottir H; Arnadottir LO; Adalsteinsson J; Gardarsdottir HR; Helgason D; Axelsson TA; Helgadottir S; Heimisdottir AA; Sigurdsson MI; Gudbjartsson T
    Laeknabladid; 2019 Juli; 105(7):319-326. PubMed ID: 31411567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Evaluation of the Pre- and Postoperative Neutrophil-Lymphocyte Ratio as a Predictor of Mortality in Patients Who Underwent Coronary Artery Bypass Grafting.
    Şahin A; Sisli E
    Heart Surg Forum; 2021 Sep; 24(5):E814-E820. PubMed ID: 34623241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome analysis of patients undergoing percutaneous coronary intervention with or without prior coronary artery bypass grafting operation].
    Song Y; Xu JJ; Tang XF; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):559-565. PubMed ID: 28738483
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
    Cho KI; Ann SH; Singh GB; Her AY; Shin ES
    PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
    Fan Z; Li Y; Ji H; Jian X
    BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
    Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.